Opioid Use Is Not Associated with Incomplete Wireless Capsule Endoscopy for Inpatient or Outpatient Procedures

Table 2

WCE transit times and completion rates grouped by opioid use and location of procedure.

	Inpatients			Outpatients
	No opioids 24 hours	Opioids 24 hours	P value^1	No opioids 24 hours	Opioids 24 hours	P value^2
GTT, min., median (IQR)	23 (8, 64)	44 (14, 87)	0.04	25 (14, 54)	24 (10, 69)	0.53
SBTT, min., median (IQR)	211 (159, 351)	240 (171, 349)	0.62	213 (142, 279)	206 (125, 305)	0.87
TTT, min., median (IQR)	260 (189, 460)	300 (223, >480)	0.11	252 (185, 323)	261 (183, 363)	0.95
Completed exam, n (%)	100 (75%)	104 (71%)	0.31	197 (88%)	77 (87%)	0.91
Gastric capsule retention, n (%)	5 (4%)	9 (6%)	0.24	9 (4%)	3 (3%)	0.93

¹Multivariable Cox proportion hazards model (transit times) or multivariable logistic regression model (completion, retention) adjusting for age, history of diabetes, history of Crohn’s, and hospital length of stay.
²Multivariable Cox proportion hazards model (transit times) or multivariable logistic regression model (completion, retention) adjusting for sex, history of Crohn’s, and prior small bowel surgery.
GTT, gastric transit time; IQR, interquartile range; min., minutes; SBTT, small bowel transit time; TTT, total transit time.